Feb 29 2024
SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 29, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S. , has released its financial results for the fourth quarter and full year 2023, which are consistent with its
Feb 20 2024
SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 20, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S. , today announced that executives from the Company will participate in a fireside chat at each of the following
Jan 22 2024
SANTA MONICA, Calif. --(BUSINESS WIRE)--Jan. 22, 2024-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities. The Company is seeking to refinance its first lien

site - Investor Tools